Susquehanna raised the firm’s price target on Varonis (VRNS) to $36 from $30 and keeps a Positive rating on the shares. The firm said the company posted strong results across the board and continues to evolve toward an all-SaaS business by year end. Susquehanna remains bullish on the data protection opportunity and see further upside from SaaS platform upsells, MDDR, and GenAI.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRNS:
- Varonis price target raised to $39 from $38 at JPMorgan
- Varonis price target raised to $33 from $28 at Barclays
- Varonis: Buy Rating Reaffirmed on Strong SaaS Momentum and Cloud Transition, Price Target Maintained at $40
- Varonis sees FY26 EPS 11c-12c, consensus 8c
- Varonis reports Q1 EPS 6c, consensus (5c)